- Home
- SISI vs BMRA Comparison
SISI vs BMRA Comparison
Compare SISI & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SISI
- BMRA
- Stock Information
- Founded
- SISI 1997
- BMRA 1971
- Country
- SISI China
- BMRA United States
- Employees
- SISI N/A
- BMRA N/A
- Industry
- SISI Medicinal Chemicals and Botanical Products
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- SISI Health Care
- BMRA Health Care
- Exchange
- SISI Nasdaq
- BMRA Nasdaq
- Market Cap
- SISI 7.0M
- BMRA 7.4M
- IPO Year
- SISI 2016
- BMRA N/A
- Fundamental
- Price
- SISI $0.45
- BMRA $0.34
- Analyst Decision
- SISI
- BMRA
- Analyst Count
- SISI 0
- BMRA 0
- Target Price
- SISI N/A
- BMRA N/A
- AVG Volume (30 Days)
- SISI 1.5M
- BMRA 1.0M
- Earning Date
- SISI 11-12-2024
- BMRA 10-11-2024
- Dividend Yield
- SISI N/A
- BMRA N/A
- EPS Growth
- SISI N/A
- BMRA N/A
- EPS
- SISI N/A
- BMRA N/A
- Revenue
- SISI $5,623,122.00
- BMRA $5,415,000.00
- Revenue This Year
- SISI N/A
- BMRA N/A
- Revenue Next Year
- SISI N/A
- BMRA N/A
- P/E Ratio
- SISI N/A
- BMRA N/A
- Revenue Growth
- SISI N/A
- BMRA 1.42
- 52 Week Low
- SISI $0.33
- BMRA $0.24
- 52 Week High
- SISI $4.90
- BMRA $2.13
- Technical
- Relative Strength Index (RSI)
- SISI 41.50
- BMRA 34.94
- Support Level
- SISI $0.37
- BMRA $0.28
- Resistance Level
- SISI $0.50
- BMRA $0.39
- Average True Range (ATR)
- SISI 0.05
- BMRA 0.06
- MACD
- SISI 0.03
- BMRA -0.01
- Stochastic Oscillator
- SISI 31.04
- BMRA 8.70
About SISI Shineco Inc.
Shineco Inc aims to care for a healthy life and improve the quality of life by providing safe, efficient, and high-quality health products and services to society. The company has researched and developed over 33 vitro diagnostic reagents and related medical devices to date, and it also produces and sells healthy and nutritious food.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.